Sélectionner la langue
Inscription gratuite
Mon panier

resDetect™ Manufacturing Process Residue Detection Solutions

resDetect™ is a series of reagent kits designed to follow international legal and regulatory requirements and guidelines for the detection of residual components in the biopharmaceutical manufacturing process. These kits cover various applications related to process-related residue detection for biopharmaceuticals, including antibody drugs, cell and gene therapies (CGT), vaccines, and more. resDetect™ kits offer comprehensive solutions for processing residue detection and cover most common residual substances such as host cell DNA, host cell protein, host cell RNA, protein A, tool enzymes, cytokines, etc.

Request Report

Browse all our resDetect™ products

Stable and Reliable — Stringent batch testing and release, with inter-batch differences less than 15%.
Regulatory Compliance — Complaint with standards and regulations of international regulatory authorities.
Global Supply— Product delivery in 1-3 days, worldwide.
Thorough Validation — Referencing guidelines such as ICH Q2 (R2) and ChP 9101.

Product Matrix

  • Cell Therapies
  • Gene Therapies
  • Therapeutic Antibodies
  • Vaccines

Cell Therapies

Cell Therapies
Cells Enrichment &
Activation
Transduction
Expansion &
Purification
Quality Control
Cryopreservation

*If you have any other development needs for residue detection products, please feel free to contact us.

Gene Therapies

Therapeutic Antibodies
Gene Transfection
Expression
Purification
Quality Control
Formulation &
Filling

*If you have any other development needs for residue detection products, please feel free to contact us.

Therapeutic Antibodies

Vaccines

Vaccines
pDNA Production
and Linearization
In Vitro Transcription
and Purification
Packaging and
Formulation Preparation
Quality Control
Formulation &
Filling

*If you have any other development needs for residue detection products, please feel free to contact us.

Resources

Related support resources

>  USP Reference Standards for Residual DNA Testing of Recombinant Biotherapeutics

>  USP 39 Published General Chapter<1132>Residual Host Cell Protein Measurement in Biopharmaceuticals

>  DNA and host cell protein impurities, routine testing versus validation studies - Scientific guideline

>  Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs): Guidance for Industry

>  Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products

Highly Recommended

>  Recombinant Factor C Endotoxin Detection Kit

>  Mycoplasma Rapid Detection Kit (qPCR)

>  resDetect™ CGT CMC Manufacturing Process Residue Detection Solutions

>  Therapeutic antibodies CMC Manufacturing Process Residue Detection Solutions


  • Background
  • Product Matrix
  • Resources
Partager vers :

[North America]: +1 800-810-0816 [Switzerland]: +41 800 040 012 [Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA [Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland

Email：order@acrobiosystems.com

Copyright © 2025 ACROBiosystems. All Rights Reserved

Nous rejoindreMentions légalesPlan du sitePolitique de confidentialitéTerms and Conditions
Retour sur le site web
Nous contacter

+41 800 040 012

order.fr@acrobiosystems.com
tech.fr@acrobiosystems.com